Market Overview:
The global DNA testing/diagnostics market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for personalized medicine, rising prevalence of genetic disorders, and technological advancements in DNA sequencing techniques. PCR-based diagnostics held the largest share of the global DNA testing/diagnostics market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to the growing demand for molecular diagnostics due to their high accuracy and reliability. ISH diagnostics are expected to grow at a highest CAGR during the forecast period owing to their ability detect chromosomal abnormalities with high accuracy.
Product Definition:
DNA Testing/Diagnostics is the process of analyzing a person's DNA in order to identify genetic disorders and mutations. The importance of DNA Testing/Diagnostics is that it can help identify both inherited and non-inherited conditions, which can allow for early diagnosis and treatment.
PCR-Based Diagnostics:
Polymerase Chain Reaction (PCR) is a technique that uses a DNA sequence as an amplification factor to produce multiple copies of a particular DNA sequence. The technology has been used in genetic testing for several years and has helped scientists understand more about human diseases. PCR-based diagnostics have become one of the most important tools in molecular diagnosis due to their high sensitivity, specificity, and ability to provide results quickly.
ISH Diagnostics:
ISH Diagnostics is a set of tests that are used for identifying genetic conditions and analyzing the DNA. The tests include looking at methylation, cytosine, and guanine in particular regions of the genome known as CpG islands to detect changes associated with diseases like cancer or diabetes.
The global ISH diagnostics & it's usage in DNA testing/diagnosis market size was valued at USD 1.6 billion in 2018.
Application Insights:
The hospital segment dominated the application segment in 2015 and accounted for more than 50.0% share of the overall revenue. The growing volume of genetic disease testing at hospitals is one of the key factors contributing to this large share. In addition, a rise in demand for rapid molecular diagnostic tests that provide results within 15 minutes is also expected to drive growth over the forecast period.
DNA testing finds wide applications in medical research as it helps detect mutations & copy number variants (CNVs), which are known to be associated with various complex diseases such as cancer and rare disorders along with their susceptibility to treatment drugs or not applicable (NAT). Thus, medical research using DNA diagnostics provides opportunities for companies operating in this market space on a global level owing to its high accuracy rate coupled with ease of use and low cost compared to other diagnosis methods used currently available within clinical settings.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to presence of well-established healthcare infrastructure, high adoption of advanced diagnostic technologies, and local presence of major players. Moreover, increasing prevalence and incidence rate of genetic disorders is expected to drive the regional market over the forecast period.
Asia Pacific is estimated to witness lucrative growth during the forecast period owing to rising target population base with increased disposable income coupled with growing awareness about availability & benefits DNA testing services in this region.
Growth Factors:
- Increasing demand for personalized medicine
- Growing public awareness about the benefits of DNA testing
- Technological advancements in DNA sequencing and analysis
- Rising prevalence of genetic disorders and chronic diseases
- Growing demand for precision medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Testing/Diagnostics Market Research Report
By Type
PCR-Based Diagnostics, ISH Diagnostics, NGS DNA Diagnosis
By Application
Hospital, Medical Research, Pharmacogenomics Diagnostic Testing
By Companies
GE Healthcare, 454 Life Sciences, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, Qiagen, Affymetrix, Agilent Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global DNA Testing/Diagnostics Market Report Segments:
The global DNA Testing/Diagnostics market is segmented on the basis of:
Types
PCR-Based Diagnostics, ISH Diagnostics, NGS DNA Diagnosis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical Research, Pharmacogenomics Diagnostic Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- 454 Life Sciences
- Abbott Laboratories
- Beckman Coulter
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Illumina
- Cephide
- Hologic
- Transgenomic
- Siemens Healthcare
- Roche Diagnostics
- Qiagen
- Affymetrix
- Agilent Technologies
Highlights of The DNA Testing/Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR-Based Diagnostics
- ISH Diagnostics
- NGS DNA Diagnosis
- By Application:
- Hospital
- Medical Research
- Pharmacogenomics Diagnostic Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Testing/Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA testing is a laboratory procedure that uses genetic material to identify individuals or families. DNA can be extracted from blood, saliva, hair, skin cells or other body tissues. The test results provide information about an individual's ancestry and potential health risks.
Some of the major players in the dna testing/diagnostics market are GE Healthcare, 454 Life Sciences, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, Qiagen, Affymetrix, Agilent Technologies.
The dna testing/diagnostics market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA Testing/Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DNA Testing/Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DNA Testing/Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DNA Testing/Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DNA Testing/Diagnostics Market Size & Forecast, 2018-2028
4.5.1 DNA Testing/Diagnostics Market Size and Y-o-Y Growth
4.5.2 DNA Testing/Diagnostics Market Absolute $ Opportunity
Chapter 5 Global DNA Testing/Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 DNA Testing/Diagnostics Market Size Forecast by Type
5.2.1 PCR-Based Diagnostics
5.2.2 ISH Diagnostics
5.2.3 NGS DNA Diagnosis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global DNA Testing/Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 DNA Testing/Diagnostics Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Medical Research
6.2.3 Pharmacogenomics Diagnostic Testing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA Testing/Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA Testing/Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America DNA Testing/Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America DNA Testing/Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America DNA Testing/Diagnostics Market Size Forecast by Type
9.6.1 PCR-Based Diagnostics
9.6.2 ISH Diagnostics
9.6.3 NGS DNA Diagnosis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America DNA Testing/Diagnostics Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Medical Research
9.10.3 Pharmacogenomics Diagnostic Testing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe DNA Testing/Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe DNA Testing/Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe DNA Testing/Diagnostics Market Size Forecast by Type
10.6.1 PCR-Based Diagnostics
10.6.2 ISH Diagnostics
10.6.3 NGS DNA Diagnosis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe DNA Testing/Diagnostics Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Medical Research
10.10.3 Pharmacogenomics Diagnostic Testing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific DNA Testing/Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific DNA Testing/Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific DNA Testing/Diagnostics Market Size Forecast by Type
11.6.1 PCR-Based Diagnostics
11.6.2 ISH Diagnostics
11.6.3 NGS DNA Diagnosis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific DNA Testing/Diagnostics Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Medical Research
11.10.3 Pharmacogenomics Diagnostic Testing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America DNA Testing/Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America DNA Testing/Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America DNA Testing/Diagnostics Market Size Forecast by Type
12.6.1 PCR-Based Diagnostics
12.6.2 ISH Diagnostics
12.6.3 NGS DNA Diagnosis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America DNA Testing/Diagnostics Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Medical Research
12.10.3 Pharmacogenomics Diagnostic Testing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) DNA Testing/Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) DNA Testing/Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) DNA Testing/Diagnostics Market Size Forecast by Type
13.6.1 PCR-Based Diagnostics
13.6.2 ISH Diagnostics
13.6.3 NGS DNA Diagnosis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) DNA Testing/Diagnostics Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Medical Research
13.10.3 Pharmacogenomics Diagnostic Testing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA Testing/Diagnostics Market: Competitive Dashboard
14.2 Global DNA Testing/Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 454 Life Sciences
14.3.3 Abbott Laboratories
14.3.4 Beckman Coulter
14.3.5 Bio-Rad Laboratories
14.3.6 Thermo Fisher Scientific
14.3.7 Illumina
14.3.8 Cephide
14.3.9 Hologic
14.3.10 Transgenomic
14.3.11 Siemens Healthcare
14.3.12 Roche Diagnostics
14.3.13 Qiagen
14.3.14 Affymetrix
14.3.15 Agilent Technologies
